|
1
|
Dokmeci D: Ibuprofen andA lzheimer's
disease. Folia Med (Plovdiv). 46:5–10. 2004.PubMed/NCBI
|
|
2
|
Bushra R and Aslam N: An overview of
clinical pharmacology of Ibuprofen. Oman Med J. 25:155–1661.
2010.PubMed/NCBI
|
|
3
|
Zaminelli T, Gradowski RW, Bassani TB,
Barbiero JK, Santiago RM, Maria-Ferreira D, Baggio CH and Vital MA:
Antidepressant and antioxidative effect of Ibuprofen in the
rotenone model of Parkinson's disease. Neurotox Res. 26:351–362.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zurita MP, Muñoz G, Sepúlveda FJ, Gómez P,
Castillo C, Burgos CF, Fuentealba J, Opazo C and Aguayo LG:
Ibuprofen inhibits the synaptic failure induced by the amyloid-β
peptide in hippocampal neurons. J Alzheimers Dis. 35:463–473.
2013.PubMed/NCBI
|
|
5
|
Cauli O, Rodrigo R, Piedrafita B, Llansola
M, Mansouri MT and Felipo V: Neuroinflammation contributes to
hypokinesia in rats with hepatic encephalopathy, Ibuprofen restores
its motor activity. J Neurosci Res. 87:1369–1374. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lim GP, Yang F, Chu T, Chen P, Beech W,
Teter B, Tran T, Ubeda O, Ashe KH, Frautschy SA and Cole GM:
Ibuprofen suppresses plaque pathology and inflammation in a mouse
model for Alzheimer's disease. J Neurosci. 20:5709–5714.
2000.PubMed/NCBI
|
|
7
|
Zawilla NH, Taha FM, Kishk NA, Farahat SA,
Farghaly M and Hussein M: Occupational exposure to aluminum and its
amyloidogenic link with cognitive functions. J Inorg Biochem.
139:57–64. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Khan KA, Kumar N, Nayak PG, Nampoothiri M,
Shenoy RR, Krishnadas N, Rao CM and Mudgal J: Impact of caffeic
acid on aluminium chloride-induced dementia in rats. J Pharm
Pharmacol. 65:1745–1752. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ahmed SS and Santosh W: Metallomic
profiling and linkage map analysis of early Parkinson's disease: A
new insight to aluminum marker for the possible diagnosis. PLoS
One. 5:e112522010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kawahara M and Kato-Negishi M: Link
between aluminum and the pathogenesis of Alzheimer's disease: The
integration of the aluminum and amyloid cascade hypotheses. Int J
Alzheimers Dis. 2011:2763932011.PubMed/NCBI
|
|
11
|
He BP and Strong MJ: Motor neuronal death
in sporadic amyotrophic lateral sclerosis (ALS) is not apoptotic.
Histopathology. Neuropathol Appl Neurobiol. 26:150–160. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pan R, Qiu S, Lu DX and Dong J: Curcumin
improves learning and memory ability and its neuroprotective
mechanism in mice. Chin Med J (Engl). 121:832–839. 2008.PubMed/NCBI
|
|
13
|
Shen LX, Jin LQ, Zhang DS and Xue GP:
Effect of osthol on memory impairment of mice in AlCl3-induced
acute senile model. Yao Xue Xue Bao. 37:178–180. 2002.PubMed/NCBI
|
|
14
|
Zaky A, Mohammad B, Moftah M, Kandeel KM
and Bassiouny AR: Apurinic/apyrimidinic endonuclease 1 is a key
modulator of aluminum-induced neuroinflammation. BMC Neurosci.
14:262013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Veerhuis R: Histological and direct
evidence for the role of complement in the neuroinflammation of AD.
Curr Alzheimer Res. 8:34–58. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Moran LB, Hickey L, Michael GJ, Derkacs M,
Christian LM, Kalaitzakis ME, Pearce RK and Graeber MB: Neuronal
pentraxin II is highly upregulated in Parkinson's disease and a
novel component of Lewy bodies. Acta Neuropathol. 115:471–478.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bjartmar L, Huberman AD, Ullian EM,
Rentería RC, Liu X, Xu W, Prezioso J, Susman MW, Stellwagen D,
Stokes CC, et al: Neuronal pentraxins mediate synaptic refinement
in the developing visual system. J Neurosci. 26:6269–6281. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schlimgen AK, Helms JA, Vogel H and Perin
MS: Neuronal pentraxin, a secreted protein with homology to acute
phase proteins of the immune system. Neuron. 14:519–526. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Goodman AR, Cardozo T, Abagyan R, Altmeyer
A, Wisniewski HG and Vilcek J: Long pentraxins, An emerging group
of proteins with diverse functions. Cytokine Growth Factor Rev.
7:191–202. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tsui CC, Copeland NG, Gilbert DJ, Jenkins
NA, Barnes C and Worley PF: Narp, a novel member of the pentraxin
family, promotes neurite outgrowth and is dynamically regulated by
neuronal activity. J Neurosci. 16:2463–2478. 1996.PubMed/NCBI
|
|
21
|
Kamenskaya MA and Thesleff S: The
neuromuscular blocking action of an isolated toxin from the elapid
(Oxyuranus scutellactus). Acta Physiol Scand. 90:716–724.
1974. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu D, Hopf C, Reddy R, Cho RW, Guo L,
Lanahan A, Petralia RS, Wenthold RJ, O'Brien RJ and Worley P: Narp
and NP1 form heterocomplexes that function in developmental and
activity-dependent synaptic plasticity. Neuron. 39:513–528. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dowton SB and McGrew SD: Rat serum amyloid
P component. Histopathology. Biochem J. 270:553–556. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Whitehead AS, Zahedi K, Rits M, Mortensen
RF and Lelias JM: Mouse C-reactive protein. Histopathology. Biochem
J. 266:283–290. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Breviario F, d'Aniello EM, Golay J, Peri
G, Bottazzi B, Bairoch A, Saccone S, Marzella R, Predazzi V, Rocchi
M, et al: Interleukin-1-inducible genes in endothelial cells.
Cloning of a new gene related to C-reactive protein and serum
amyloid P component. J Biol Chem. 267:22190–22197. 1992.PubMed/NCBI
|
|
26
|
Abad MA, Enguita M, DeGregorio-Rocasolano
N, Ferrer I and Trullas R: Neuronal pentraxin 1 contributes to the
neuronal damage evoked by amyloid-beta and is overexpressed in
dystrophic neurites in Alzheimer's brain. J Neurosci.
26:12735–12747. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Walsh DM and Selkoe DJ: Deciphering the
molecular basis of memory failure in Alzheimer's disease. Neuron.
44:181–193. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
DeGregorio-Rocasolano N, Gasull T and
Trullas R: Overexpression of neuronal pentraxin 1 is involved in
neuronal death evoked by low K(+) in cerebellar granule
cells. J Biol Chem. 276:796–803. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hashmi AN, Yaqinuddin A and Ahmed T:
Pharmacological effects of Ibuprofen on learning and memory,
muscarinic receptors gene expression and APP isoforms level in
pre-frontal cortex of AlCl3-induced toxicity mouse model. Int J
Neurosci. 125:277–287. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ahmed T and Gilani AH: Inhibitory effect
of curcuminoids on acetylcholinesterase activity and attenuation of
scopolamine-induced amnesia may explain medicinal use of turmeric
in Alzheimer's disease. Pharmacol Biochem Behav. 91:554–559. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Choleris E, Thomas AW, Kavaliers M and
Prato FS: A detailed ethological analysis of the mouse open field
test, Effects of diazepam, chlordiazepoxide and an extremely low
frequency pulsed magnetic field. Neurosci Biobehav Rev. 25:235–260.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ahmed T, Enam SA and Gilani AH:
Curcuminoids enhance memory in an amyloid-infused rat model of
Alzheimer's disease. Neuroscience. 169:1296–1306. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Asanuma M, Miyazaki I and Ogawa N:
Neuroprotective effects of nonsteroidal anti-inflammatory drugs on
neurodegenerative diseases. Curr Pharm Des. 10:695–700. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Parepally JM, Mandula H and Smith QR:
Brain uptake of nonsteroidal anti-inflammatory drugs, Ibuprofen,
flurbiprofen, and indomethacin. Pharm Res. 23:873–881. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bromley-Brits K, Deng Y and Song W: Morris
water maze test for learning and memory deficits in Alzheimer's
disease model mice. J Vis Exp. (53)2920:2011.
|
|
36
|
Walsh RN and Cummins RA: The Open-Field
Test: A critical review. Psychol Bull. 83:482–504. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Blanchard DC, Griebel G and Blanchard RJ:
Mouse defensive behaviors, Pharmacological and behavioral assays
for anxiety and panic. Neurosci Biobehav Rev. 25:205–218. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ferretti L, McCurry SM, Logsdon R, Gibbons
L and Teri L: Anxiety and Alzheimer's disease. J Geriatr Psychiatry
Neurol. 14:52–58. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Akiyama H, Barger S, Barnum S, Bradt B,
Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich
BL, et al: Inflammation and Alzheimer's disease. Neurobiol Aging.
21:383–421. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tuppo EE and Arias HR: The role of
inflammation in Alzheimer's disease. Int J Biochem Cell Biol.
37:289–305. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ren K and Torres R: Role of
interleukin-1beta during pain and inflammation. Brain Res Rev.
60:57–64. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Mrak RE and Griffin WS: Interleukin-1,
neuroinflammation and Alzheimer's disease. Neurobiol Aging.
22:903–908. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cacabelos R, Alvarez XA, Fernández-Novoa
L, Franco A, Mangues R, Pellicer A and Nishimura T: Brain
interleukin-1 beta in Alzheimer's disease and vascular dementia.
Methods Find Exp Clin Pharmacol. 16:141–151. 1994.PubMed/NCBI
|
|
44
|
Ahmed T and Gilani AH: A comparative study
of curcuminoids to measure their effect on inflammatory and
apoptotic gene expression in an Aβ plus ibotenic acid-infused rat
model of Alzheimer's disease. Brain Res. 1400:1–18. 2011.
View Article : Google Scholar : PubMed/NCBI
|
